SARIN ARADHANA 4
4 · ALEXION PHARMACEUTICALS, INC. · Filed Jun 24, 2019
Insider Transaction Report
Form 4
SARIN ARADHANA
EVP, CFO
Transactions
- Sale
Common Stock, par value $.0001 per share
[F1]2019-06-21$132.00/sh−578$76,296→ 30,201 total
Footnotes (1)
- [F1]The transactions reported by this Form 4 are made pursuant to the terms of a sales plan designed to meet the requirements of Rule 10b5-1(c)(1) of the Securities Exchange Act.
Signature
/s/ Douglas Barry, Attorney-in-Fact for Aradhana Sarin|2019-06-24